Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
REFI
4001
Chicago Atlantic Real Estate Finance
REFI
$274M
| $971K | ﹤0.01% |
64,085
-38,771
| -38% | -$563K |
|
4002
Smith & Wesson
SWBI
$573M
| $969K | ﹤0.01% |
74,302
+2,139
| +3% | +$26.1K |
|
4003
CALL
Smith & Nephew
SNN
$12.1B
| $968K | ﹤0.01% |
30,000
-142,900
| -83% | -$4.42M |
|
|
4004
PUT
Smith & Nephew
SNN
$12.1B
| $968K | ﹤0.01% |
+30,000
| New | +$928K |
|
4005
John B. Sanfilippo & Son
JBSS
$873M
| $964K | ﹤0.01% |
8,219
+2,420
| +42% | +$271K |
|
4006
First Capital
FCAP
$209M
| $962K | ﹤0.01% |
31,114
-3,808
| -11% | -$99.2K |
|
4007
CALL
Roku
ROKU
$23.4B
| $959K | ﹤0.01% |
15,000
-9,500
| -39% | -$577K |
|
4008
Phibro Animal Health
PAHC
$1.53B
| $959K | ﹤0.01% |
69,996
+13,364
| +24% | +$191K |
|
4009
PUT
UGI
UGI
$8.15B
| $957K | ﹤0.01% |
+35,500
| New | +$1.08M |
|
4010
Fulgent Genetics
FLGT
$540M
| $956K | ﹤0.01% |
25,807
-25,820
| -50% | -$900K |
|
4011
Ennis
EBF
$544M
| $955K | ﹤0.01% |
46,877
-44,493
| -49% | -$898K |
|
4012
CALL
Newell Brands
NWL
$2.63B
| $955K | ﹤0.01% |
109,800
-630,500
| -85% | -$6.27M |
|
|
4013
CALL
UGI
UGI
$8.15B
| $955K | ﹤0.01% |
+35,400
| New | +$1.07M |
|
4014
Sensient Technologies
SXT
$5.75B
| $953K | ﹤0.01% |
13,394
+10,374
| +344% | +$770K |
|
|
EB
4015
DELISTED
Eventbrite
EB
| $952K | ﹤0.01% |
99,697
-39,469
| -28% | -$310K |
|
4016
Vanguard Health Care ETF
VHT
$19.3B
| $952K | ﹤0.01% |
+3,889
| New | +$946K |
|
|
SSBK
4017
DELISTED
Southern States Bancshares
SSBK
| $950K | ﹤0.01% |
45,038
-53,448
| -54% | -$1.15M |
|
4018
Suncor Energy
SU
$76.5B
| $948K | ﹤0.01% |
32,330
-3,262,904
| -99% | -$97.6M |
|
4019
GoDaddy
GDDY
$12.4B
| $948K | ﹤0.01% |
12,616
-109,877
| -90% | -$8.11M |
|
|
HSHP
4020
Himalaya Shipping
HSHP
$787M
| $947K | ﹤0.01% |
170,298
-230,618
| -58% | -$1.31M |
|
|
RVNC
4021
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $944K | ﹤0.01% |
+37,300
| New | +$1.16M |
|
4022
Columbus McKinnon
CMCO
$520M
| $944K | ﹤0.01% |
23,220
+10,363
| +81% | +$383K |
|
|
IMGN
4023
PUT
DELISTED
Immunogen Inc
IMGN
| $944K | ﹤0.01% |
50,000
-200,000
| -80% | -$2.36M |
|
|
SWN
4024
PUT
DELISTED
Southwestern Energy Company
SWN
| $941K | ﹤0.01% |
156,500
+79,100
| +102% | +$408K |
|
4025
CALL
ArcelorMittal
MT
$56.1B
| $940K | ﹤0.01% |
34,400
-31,000
| -47% | -$852K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.